Yarema Kristin 4
4 · Atara Biotherapeutics, Inc. · Filed May 20, 2021
Insider Transaction Report
Form 4
Yarema Kristin
Chief Commercial Officer
Transactions
- Sale
Common Stock
2021-05-18$14.55/sh−761$11,073→ 91,528 total
Footnotes (2)
- [F1]Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted Restricted Stock Units.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 18, 2021 and May 19, 2021 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.